Corifollitropin α followed by menotropin for poor ovarian responders' trial (COMPORT): A protocol of a multicentre randomised trial

BMJ Open

Volumn 3, Issue 6, 2013, Pages

  Polyzos, Nikolaos P ^a   Camus, Michel ^a   Llacer, Joaquin ^b   Pantos, Konstantinos ^c   Tournaye, Herman ^a  

^a CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

^b Instituto Bernabeu   (Spain)

^c Genesis Athens Hospital   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CORIFOLLITROPIN ALFA; HUMAN MENOPAUSAL GONADOTROPIN; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CONTROLLED STUDY; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; FOLLOW UP; GESTATIONAL AGE; GESTATIONAL SAC; HEART FUNCTION; HORMONAL THERAPY; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MULTICENTER STUDY; OOCYTE; OOCYTE RETRIEVAL; OPEN STUDY; OUTCOME ASSESSMENT; OVARY STIMULATION; PARALLEL DESIGN; PATIENT SAFETY; PHASE 3 CLINICAL TRIAL; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE;

EID: 84878760513     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-002938     Document Type: Article

References (10)

1. HFEA. HFEA Fertility Trends and Figures 2011-Annual Register Report, 2011. http://www.hfea.gov.uk/docs/HFEA-Fertility-Trends-and-Figures-2011--- Annual-Register-Report.pdf
2. Oudendijk JF, Yarde F, Eijkemans MJ, et al . The poor responder in IVF: is the prognosis always poor? A systematic review. Hum Reprod Update 2012;18:1-11.
3. Ubaldi FM, Rienzi L, Ferrero S, et al. Management of poor responders in IVF. Reprod Biomed Online 2005;10:235-46. (Pubitemid 40246642)
4. El-Toukhy T, Khalaf Y, Hart R, et al. Young age does not protect against the adverse effects of reduced ovarian reserve-an eight year study. Hum Reprod 2002;17:1519-24. (Pubitemid 34661801)
5. Sunkara SK, Tuthill J, Khairy M, et al. Pituitary suppression regimens in poor responders undergoing IVF treatment: a systematic review and meta-analysis. Reprod Biomed Online 2007;15:539-46. (Pubitemid 350167076)
6. Polyzos NP, Devroey P. A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel? Fertil Steril 2011;96:1058-61 e7.
7. Ferraretti AP, La Marca A, Fauser BC, et al. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod 2011;26:1616-24.
8. Polyzos NP, Blockeel C, Verpoest W, et al. Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria. Hum Reprod 2012;27:3481-6.
9. Polyzos NP, Devos M, Humaidan P, et al. Corifollitropin alfa followed by rFSH in a GnRH antagonist protocol for poor ovarian responder patients: an observational pilot study. Fertil Steril 2013;99:422-6.
10. Polyzos NP, De Vos M, Corona R, et al. Addition of highly purified HMG after corifollitropin alfa in antagonist-treated poor ovarian responders: a pilot study. Hum Reprod 2013;28:1254-60.